Home
Team
Projects
Publications
Equipment
Posts
Events
Vacancies
Light
Dark
Automatic
Jim Middleton
Latest
Soluble syndecan-3 binds chemokines, reduces leukocyte migration in vitro and ameliorates disease severity in models of rheumatoid arthritis
Novel Anti-Inflammatory Peptides Based on Chemokine-Glycosaminoglycan Interactions Reduce Leukocyte Migration and Disease Severity in a Model of Rheumatoid Arthritis
Murine Mesenchymal Stem Cell-Conditioned Medium Reduces Disease Severity and Immune Responses in Inflammatory Arthritis
Homing of Mesenchymal Stem Cells
An initial investigation into endothelial CC chemokine expression in the human rheumatoid synovium
Mesenchymal Stem Cell Therapy in Rheumatoid Arthritis
Novel Identification of LYVE-1 Positive Macrophages in Rheumatoid Synovial Tissue
Intra-articular injection of mesenchymal stem cells leads to reduced inflammation and cartilage damage in murine antigen-induced arthritis
A chemokine self-presentation mechanism involving formation of endothelial surface microstructures
Is Chemokine Receptor CCR9 Required for Synovitis in Rheumatoid Arthritis? Deficiency of CCR9 in a Murine Model of Antigen-Induced Arthritis
Syndecan-3 is selectively pro-inflammatory in the joint and contributes to antigen-induced arthritis in mice
Murine Mesenchymal Stem Cells Exhibit a Restricted Repertoire of Functional Chemokine Receptors: Comparison with Human
Cite
×